Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Retained Earnings (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Retained Earnings readings, the most recent being $13.1 million for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 125.86% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.1 million, a 125.86% increase, with the full-year FY2025 number at $13.1 million, up 125.86% from a year prior.
  • Retained Earnings hit $13.1 million in Q4 2025 for Neurocrine Biosciences, down from $294.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $294.0 million in Q3 2025 to a low of -$693.3 million in Q1 2021.
  • Median Retained Earnings over the past 5 years was -$8.4 million (2022), compared with a mean of -$204.2 million.
  • Biggest five-year swings in Retained Earnings: tumbled 35422.22% in 2021 and later skyrocketed 4870.59% in 2024.
  • Neurocrine Biosciences' Retained Earnings stood at -$635.8 million in 2021, then surged by 36.02% to -$406.8 million in 2022, then surged by 101.72% to $7.0 million in 2023, then fell by 17.14% to $5.8 million in 2024, then skyrocketed by 125.86% to $13.1 million in 2025.
  • The last three reported values for Retained Earnings were $13.1 million (Q4 2025), $294.0 million (Q3 2025), and $84.5 million (Q2 2025) per Business Quant data.